Rationale and study design of the CardioGene Study: Genomics of in-stent restenosis

Santhi K. Ganesh, Kimberly A. Skelding, Laxmi Mehta, Kathleen O'Neill, Jungnam Joo, Gang Zheng, James Goldstein, Robert Simari, Eric Billings, Nancy L. Geller, David Holmes, William W. O'Neill, Elizabeth G. Nabel

Research output: Contribution to journalArticle

28 Scopus citations
Original languageEnglish (US)
Pages (from-to)952-966
Number of pages15
JournalPharmacogenomics
Volume5
Issue number7
DOIs
StatePublished - Oct 2004

Keywords

  • Cardiovascular disease
  • Genetic susceptibility
  • Genomics
  • Genotyping
  • Proteomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Ganesh, S. K., Skelding, K. A., Mehta, L., O'Neill, K., Joo, J., Zheng, G., Goldstein, J., Simari, R., Billings, E., Geller, N. L., Holmes, D., O'Neill, W. W., & Nabel, E. G. (2004). Rationale and study design of the CardioGene Study: Genomics of in-stent restenosis. Pharmacogenomics, 5(7), 952-966. https://doi.org/10.1517/14622416.5.7.949